Ivan Hiew, NP
NPI 1942902168 · Family Nurse Practitioner · Longmont, CO
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1942902168
- Entity type
- Individual
- Primary specialty
- Family Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- NP
- Sex
- Male
- Sole proprietor
- No
- License
- APN.0998528-NP (CO)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
3 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
317 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 200 | $73 |
| Automated Urinalysis Test81003 | 27 | $2 |
| Respiratory Infectious Agent Detection By Rna for Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, and Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected0241U | 26 | $140 |
| Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212 | 24 | $53 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203 | 17 | $96 |
| Detection Test By Nucleic Acid for Strep (streptococcus, Group A), Amplified Probe Technique |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 12 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Prednisone | 61 | 58 |
| Nirmatrelvir/Ritonavirbrand: Paxlovid | 57 | 57 |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 33 | 31 |
| Amoxicillin/Potassium Clavbrand: Amoxicillin-Clavulanate Potass | 31 | 30 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 24 | 22 |
| Cephalexin | 24 | 22 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$43 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2023-03-21
- Last updated
- 2023-03-21
- Certified
- 2023-03-21
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.